乐鱼在线
乐鱼在线:About Henlius
Company Profile
乐鱼在线:Corporate Culture
Honor
Board of Directors
乐鱼在线:Management Team
乐鱼在线:Advisory Committee
Product
乐鱼在线:Marketed Products
乐鱼在线:Products in R&D
Clinical Trial
乐鱼在线:Science & Technology
乐鱼在线:R&D Result
乐鱼在线:Innovation Centre
乐鱼在线:Technology Platform
乐鱼在线:Quality Management
乐鱼在线:Manufacturing
Collaborations
乐鱼在线:Investor Relations
Information Disclosure
Corporate Governance
Financial Reports
乐鱼在线:Stock Info
IR Calendar
乐鱼在线:Investor Presentation
Analyst Coverage
Contact Information
Media
Press Release
乐鱼在线:Multi-media
乐鱼在线:Media Reports
Media Enquiry
Careers
乐鱼在线:Talent Philosophy
乐鱼在线:Staff Life
乐鱼在线:Training and Development
Contact Us
Contact Information
Customer Message
Privacy
Legal Statement
Compliance
EN
简体
EN
繁體
Home
乐鱼在线:About Henlius
乐鱼在线:Company Profile
Corporate Culture
Honor
Board of Directors
乐鱼在线:Management Team
Advisory Committee
Product
乐鱼在线:Marketed Products
Products in R&D
Clinical Trial
乐鱼在线:Science & Technology
R&D Result
Innovation Centre
乐鱼在线:Technology Platform
乐鱼在线:Quality Management
Manufacturing
Collaborations
乐鱼在线:Investor Relations
Information Disclosure
乐鱼在线:Listing Documents
乐鱼在线:Announcement & Circulars
乐鱼在线:Corporate Governance
乐鱼在线:Financial Reports
乐鱼在线:Stock Info
IR Calendar
Investor Presentation
乐鱼在线:Analyst Coverage
乐鱼在线:Contact Information
Media
乐鱼在线:Press Release
2022
2021
2020
2019
2018
2017
2016
2015
2014
乐鱼在线:Multi-media
Company
Event
乐鱼在线:Popular Science
乐鱼在线:Media Reports
乐鱼在线:Media Enquiry
Careers
Talent Philosophy
乐鱼在线:Staff Life
Training and Development
乐鱼在线:Job Opportunities
Contact Us
Contact Information
乐鱼在线:Customer Message
Privacy
Legal Statement
乐鱼在线:Compliance
Be the most trusted biotech company
Press Release
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
乐鱼在线:Multi-media
Company
乐鱼在线:Popular Science
乐鱼在线:Highlights
Download
乐鱼在线:Media Reports
Media Enquiry
2020-07-29
Henlius and Accord Healthcare Receive EMA Approval for Zercepac®, trastuzumab biosimilar
2020-06-24
Cooperation with Accord Upgraded: to Bring High Quality Products to More Patients
2020-06-16
Phase 3 Trial of Henlius Bevacizumab Biosimilar HLX04 in Metastatic Colorectal Cancer Met Study Primary Endpoint
2020-06-05
Exclusive Interview with Henlius Senior Vice President of Manufacturing & Engineering, Mrs Wei Huang
2020-05-31
Henlius and Accord Receive Positive CHMP Opinion for Oncology Biosimilar, HLX02 (Trastuzumab)
2020-05-27
Henlius Received IND Approval for Denosumab Biosimilar HLX14 from NMPA
2020-04-24
First Patient in Overseas Trial Site Dosed in an International Multi-centre Phase 3 Study of Henlius Anti-PD-1 mAb HLX10 in ES-SCLC
2020-04-23
Henlius Receives EU GMP Certificate for HLX02 (Trastuzumab for Injection)
2020-04-23
First Patient in Overseas Trial Site Dosed in the Multi-centre International Phase 3 Study of Henlius Anti-PD-1 mAb for the Treatment of Lung Cancer
1
2
3
4
5
var _hmt = _hmt || []; (function() { var hm = document.createElement("script"); hm.src = "https://hm.baidu.com/hm.js?90c4d9819bca8c9bf01e7898dd269864"; var s = document.getElementsByTagName("script")[0]; s.parentNode.insertBefore(hm, s); })(); !function(p){"use strict";!function(t){var s=window,e=document,i=p,c="".concat("https:"===e.location.protocol?"https://":"http://","sdk.51.la/js-sdk-pro.min.js"),n=e.createElement("script"),r=e.getElementsByTagName("script")[0];n.type="text/javascript",n.setAttribute("charset","UTF-8"),n.async=!0,n.src=c,n.id="LA_COLLECT",i.d=n;var o=function(){s.LA.ids.push(i)};s.LA?s.LA.ids&&o():(s.LA=p,s.LA.ids=[],o()),r.parentNode.insertBefore(n,r)}()}({id:"K9y7iMpaU8NS42Fm",ck:"K9y7iMpaU8NS42Fm"});
乐鱼在线官网-乐鱼在线
ufc下注官网_ufc竞猜平台【新版本下载】
ufc下注_ufc押注网站
ufc下注官网_ufc竞猜软件【注册登录】
天博APP-天博APP下载-天博APP官方网站